Genetically distinct within-host subpopulations of hepatitis C virus persist after Direct-Acting Antiviral treatment failure

• Published in: PLoS pathogens Vol. 21; no. 4; p. e1012959
• Main Authors: Zhao, Lele, Hall, Matthew, Giridhar, Prahalad, Ghafari, Mahan, Kemp, Steven, Chai, Haiting, Klenerman, Paul, Barnes, Eleanor, Ansari, M. Azim, Lythgoe, Katrina
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 01.04.2025; Public Library of Science (PLoS)
• Subjects: Analysis; Antiviral agents; Antiviral Agents - therapeutic use; Biological response modifiers; Biology and Life Sciences; Computer and Information Sciences; Drug therapy; Female; Genetic aspects; Genome, Viral; Genomics; Health aspects; Hepacivirus - drug effects; Hepacivirus - genetics; Hepatitis C; Hepatitis C virus; Hepatitis C, Chronic - drug therapy; Hepatitis C, Chronic - genetics; Hepatitis C, Chronic - virology; Humans; Identification and classification; Infection; Interferon; Male; Medicine and health sciences; Natural history; Patient outcomes; Treatment Failure; Viral genetics; United Kingdom
• ISSN: 1553-7374; 1553-7366; 1553-7374
• DOI: 10.1371/journal.ppat.1012959

Analysis of viral genetic data has previously revealed distinct within-host population structures in both untreated and interferon-treated chronic hepatitis C virus (HCV) infections. While multiple subpopulations persisted during the infection, each subpopulation was observed only intermittently. However, it was unknown whether similar patterns were also present after Direct-Acting Antiviral (DAA) treatment, where viral populations were often assumed to go through narrow bottlenecks. Here we tested for the maintenance of population structure after DAA treatment failure, and whether there were different evolutionary rates along distinct lineages where they were observed. We analysed whole-genome next-generation sequencing data generated from a randomised study using DAAs (the BOSON study). We focused on samples collected from patients (N=84) who did not achieve sustained virological response (i.e., treatment failure) and had sequenced virus from multiple timepoints. Given the short-read nature of the data, we used a number of methods to identify distinct within-host lineages including tracking concordance in intra-host nucleotide variant (iSNV) frequencies, applying sequenced-based and tree-based clustering algorithms to sliding windows along the genome, and haplotype reconstruction. Distinct viral subpopulations were maintained among a high proportion of individuals post DAA treatment failure. Using maximum likelihood modelling and model comparison, we found an overdispersion of viral evolutionary rates among individuals, and significant differences in evolutionary rates between lineages within individuals. These results suggest the virus is compartmentalised within individuals, with the varying evolutionary rates due to different viral replication rates and/or different selection pressures. We endorse lineage awareness in future analyses of HCV evolution and infections to avoid conflating patterns from distinct lineages, and to recognise the likely existence of unsampled subpopulations.